EcoDrugPlus

Glutamate Ionotropic Receptor Kainate Type Subunit 5

Ensembl ID : ENSPLAG00000015133
Gene Symbol: GRIK5
3 Cross references
230 Possible Orthologues:

Glutamate Metabotropic Receptor 2

Ensembl ID : ENSPLAG00000014472
Gene Symbol: GRM2
3 Cross references
206 Possible Orthologues:

Glutamate Metabotropic Receptor 3

Ensembl ID : ENSPLAG00000012257
Gene Symbol: GRM3
3 Cross references
215 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSPLAG00000008102
Gene Symbol: GRM4
3 Cross references
196 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSPLAG00000012444
Gene Symbol: GRM4
3 Cross references
207 Possible Orthologues:

Glutamate Metabotropic Receptor 5

Ensembl ID : ENSPLAG00000017775
Gene Symbol: GRM5
3 Cross references
214 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSPLAG00000014824
Gene Symbol: LOC106938978
2 Cross references
249 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSPLAG00000007161
Gene Symbol: LOC106964583
3 Cross references
250 Possible Orthologues:

Glutamate Receptor 4-Like

Ensembl ID : ENSPLAG00000021658
Gene Symbol: LOC106936764
3 Cross references
249 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2a-Like

Ensembl ID : ENSPLAG00000009125
Gene Symbol: LOC106962579
2 Cross references
98 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2b-Like

Ensembl ID : ENSPLAG00000010849
Gene Symbol: LOC106952308
3 Cross references
250 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2c-Like

Ensembl ID : ENSPLAG00000015007
Gene Symbol: LOC106957590
2 Cross references
115 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).